Free Trial
→ Reagan’s former tech advisor sharing bombshell announcement (From Banyan Hill Publishing) (Ad)tc pixel Free CELC Stock Alerts

Celcuity (CELC) Financials

Celcuity logo
$53.90 -1.18 (-2.13%)
As of 01:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Celcuity

Annual Income Statements for Celcuity

This table shows Celcuity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Consolidated Net Income / (Loss)		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Net Income / (Loss) Continuing Operations		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Total Pre-Tax Income 		-3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Total Operating Income		 -3.33 -5.95 -7.93 -7.81 -9.56 -28 -39 -66 -113
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 3.33 5.95 7.93 7.81 9.56 28 39 66 113
Selling, General & Admin Expense		 0.26 0.97 1.61 1.54 1.87 2.60 4.10 5.64 9.06
Research & Development Expense		 3.06 4.98 6.33 6.27 7.68 26 35 61 104
Total Other Income / (Expense), net		 0.02 -0.30 0.45 0.45 0.08 -1.25 -0.98 2.45 1.49
Interest Expense		 0.00 0.45 0.00 0.00 0.00 1.26 2.11 5.33 10
Interest & Investment Income		 0.02 0.15 0.45 0.45 0.08 0.01 1.13 7.78 12
Income Tax Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) ($2.64) ($2.69) ($2.83)
Weighted Average Basic Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 15.42M 23.68M 39.45M
Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) - ($2.64) ($2.69) ($2.83)
Weighted Average Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 15.42M 23.68M 39.45M
Weighted Average Basic & Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 21.69M 30.45M 37.84M

Quarterly Income Statements for Celcuity

This table shows Celcuity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Consolidated Net Income / (Loss)		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Net Income / (Loss) Continuing Operations		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Total Pre-Tax Income 		-11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Total Operating Income		 -11 -12 -13 -15 -19 -20 -22 -24 -30 -36 -36
Total Gross Profit		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 11 12 13 15 19 20 22 24 30 36 36
Selling, General & Admin Expense		 1.02 1.04 1.27 1.31 1.41 1.65 1.85 1.79 2.47 2.96 3.91
Research & Development Expense		 9.62 11 11 14 17 18 21 22 28 33 32
Total Other Income / (Expense), net		 -0.25 0.06 0.61 0.47 0.49 0.88 0.88 0.56 0.54 -0.49 -0.86
Interest Expense		 0.54 0.68 1.24 1.31 1.37 1.40 1.40 2.26 3.34 3.28 3.18
Interest & Investment Income		 0.29 0.74 1.85 1.78 1.87 2.28 2.28 2.82 3.61 3.05 2.32
Income Tax Expense		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Basic Earnings per Share		 ($0.75) ($0.69) ($0.55) ($0.66) ($0.83) ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86)
Weighted Average Basic Shares Outstanding		 14.94M 15.42M 21.68M 21.96M 22.12M 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M
Diluted Earnings per Share		 ($0.75) - ($0.55) ($0.66) ($0.83) ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86)
Weighted Average Diluted Shares Outstanding		 14.94M 15.42M 21.68M 21.96M 22.12M 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M
Weighted Average Basic & Diluted Shares Outstanding		 15.46M 21.69M 21.96M 22.09M 24.20M 30.45M 31.23M 37.03M 37.13M 37.84M 37.87M

Annual Cash Flow Statements for Celcuity

This table details how cash moves in and out of Celcuity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 0.79 -3.22 13 2.79 -7.10 73 -60 6.09 -8.15
Net Cash From Operating Activities		 -2.89 -4.95 -6.08 -6.00 -7.15 -20 -36 -54 -83
Net Cash From Continuing Operating Activities		 -2.89 -4.95 -6.08 -5.66 -7.15 -20 -36 -54 -83
Net Income / (Loss) Continuing Operations		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Consolidated Net Income / (Loss)		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Depreciation Expense		 0.07 0.10 0.22 0.34 0.39 0.30 0.21 0.14 0.13
Amortization Expense		 - - - - 0.00 0.27 0.40 0.24 1.33
Non-Cash Adjustments To Reconcile Net Income		 0.19 1.33 1.25 1.08 1.74 7.90 4.95 5.72 8.50
Changes in Operating Assets and Liabilities, net		 0.16 -0.13 -0.07 -0.05 0.20 0.82 -1.19 3.86 18
Net Cash From Investing Activities		 -0.04 -29 19 8.53 -0.09 -0.08 -144 -5.01 -63
Net Cash From Continuing Investing Activities		 -0.04 -29 19 9.29 -0.09 -0.08 -144 -5.01 -63
Purchase of Property, Plant & Equipment		 -0.04 -0.24 -0.63 -0.38 -0.09 -0.08 -0.16 -0.10 -0.25
Purchase of Investments		 0.00 -29 -3.24 - - 0.00 -144 -315 -705
Sale and/or Maturity of Investments		 - 0.00 23 8.91 - - 0.00 310 642
Net Cash From Financing Activities		 3.72 31 0.24 0.26 0.14 93 120 65 138
Net Cash From Continuing Financing Activities		 3.72 31 0.24 0.27 0.14 93 120 65 138
Repayment of Debt		 0.00 -0.04 - - - 14 20 -0.00 0.00
Issuance of Debt		 0.00 7.49 - - 0.00 - - 0.00 59
Issuance of Common Equity		 3.72 24 0.14 0.09 0.18 0.00 96 65 64
Other Financing Activities, net		 0.00 0.00 0.10 0.18 -0.04 79 4.92 0.36 15
Cash Interest Paid		 - - - - 0.00 0.69 1.26 3.27 7.59

Quarterly Cash Flow Statements for Celcuity

This table details how cash moves in and out of Celcuity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -9.43 -33 9.07 -1.40 -6.48 4.90 0.55 -0.76 -18 9.91 -6.04
Net Cash From Operating Activities		 -9.31 -9.48 -13 -9.66 -13 -19 -17 -18 -21 -28 -36
Net Cash From Continuing Operating Activities		 -9.31 -9.48 -13 -9.66 -13 -19 -17 -18 -21 -28 -36
Net Income / (Loss) Continuing Operations		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Consolidated Net Income / (Loss)		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Depreciation Expense		 0.05 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.04 0.04
Amortization Expense		 0.10 0.11 0.06 0.06 0.06 0.06 0.07 0.24 0.48 0.55 0.55
Non-Cash Adjustments To Reconcile Net Income		 1.33 1.14 0.01 3.47 1.09 1.15 1.64 1.32 1.71 3.83 1.75
Changes in Operating Assets and Liabilities, net		 0.10 0.80 -1.04 1.36 4.47 -0.93 2.81 4.07 7.01 4.47 -1.19
Net Cash From Investing Activities		 -0.01 -144 22 8.09 6.25 -41 3.54 -106 1.90 38 24
Net Cash From Continuing Investing Activities		 -0.01 -144 22 8.09 6.25 -41 3.54 -106 1.90 38 24
Purchase of Property, Plant & Equipment		 -0.01 -0.11 -0.01 -0.00 -0.05 -0.03 -0.09 -0.06 -0.05 -0.05 -0.06
Purchase of Investments		 - -144 -3.13 -111 -71 -130 -121 -241 -153 -190 -42
Sale and/or Maturity of Investments		 - - 25 119 77 89 125 135 155 227 67
Net Cash From Financing Activities		 -0.11 121 0.07 0.17 0.02 65 14 123 0.80 0.12 5.55
Net Cash From Continuing Financing Activities		 -0.11 121 0.07 0.17 0.02 65 14 123 0.80 0.12 5.55
Other Financing Activities, net		 -0.10 5.14 0.07 0.07 0.02 0.21 14 0.40 0.82 -0.02 5.55
Cash Interest Paid		 0.33 0.42 0.75 0.81 0.85 0.87 0.87 1.63 2.61 2.47 2.38

Annual Balance Sheets for Celcuity

This table presents Celcuity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 6.06 32 26 20 13 86 176 191 245
Total Current Assets		 5.91 24 25 19 12 85 175 191 245
Cash & Equivalents		 5.86 2.64 16 19 12 84 25 31 23
Short-Term Investments		 0.00 22 8.95 - - 0.00 144 150 213
Other Current Assets		 0.01 0.03 0.05 0.05 0.02 0.04 6.60 10 9.47
Plant, Property, & Equipment, net		 0.14 0.28 0.81 0.83 0.56 0.31 0.26 0.23 0.34
Total Noncurrent Assets		 0.00 7.21 0.00 0.20 0.23 0.24 0.25 0.40 0.22
Other Noncurrent Operating Assets		 - - 0.00 0.20 0.23 0.24 0.25 0.40 0.22
Total Liabilities & Shareholders' Equity		 6.06 32 26 20 13 86 176 191 245
Total Liabilities		 0.45 0.58 0.68 0.98 1.25 17 42 51 130
Total Current Liabilities		 0.45 0.58 0.66 0.91 1.19 2.51 6.88 14 32
Accounts Payable		 0.33 0.07 0.12 0.14 0.22 1.51 2.63 5.08 9.37
Accrued Expenses		 0.11 0.51 0.54 0.58 0.77 0.80 4.06 8.93 22
Other Current Liabilities		 - - 0.01 0.18 0.19 0.20 0.19 0.18 0.17
Total Noncurrent Liabilities		 0.00 0.00 0.02 0.07 0.07 15 35 37 98
Long-Term Debt		 - - - - 0.00 15 35 37 98
Other Noncurrent Operating Liabilities		 - - 0.00 0.07 0.06 0.06 0.06 0.23 0.05
Commitments & Contingencies		 0.00 0.00 - - - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 5.61 31 25 19 12 69 134 140 116
Total Preferred & Common Equity		 5.61 31 25 19 12 69 134 140 116
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 5.61 31 25 19 12 69 134 140 116
Common Stock		 14 33 35 36 38 125 230 300 387
Retained Earnings		 -8.33 -2.01 -9.49 -17 -26 -56 -96 -160 -272

Quarterly Balance Sheets for Celcuity

This table presents Celcuity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 65 165 154 142 188 293 273 218
Total Current Assets		 65 164 153 142 188 292 272 218
Cash & Equivalents		 57 34 32 26 31 30 13 16
Short-Term Investments		 - 124 114 108 146 253 251 189
Other Current Assets		 0.37 0.06 0.10 - 9.86 8.86 8.38 12
Plant, Property, & Equipment, net		 0.30 0.22 0.21 0.22 0.31 0.31 0.34 0.36
Total Noncurrent Assets		 0.30 0.55 0.50 0.45 0.35 0.31 0.26 0.17
Other Noncurrent Operating Assets		 0.30 0.55 0.50 0.45 0.35 0.31 0.26 0.17
Total Liabilities & Shareholders' Equity		 65 165 154 142 188 293 273 218
Total Liabilities		 22 42 43 49 54 116 123 131
Total Current Liabilities		 6.65 5.81 7.08 13 17 20 26 33
Accounts Payable		 3.17 2.57 3.02 5.63 5.28 6.20 9.16 9.93
Accrued Expenses		 3.28 3.04 3.87 6.89 11 13 17 23
Other Current Liabilities		 0.20 0.20 0.19 0.19 0.18 0.18 0.18 0.17
Total Noncurrent Liabilities		 15 36 36 37 38 96 97 99
Long-Term Debt		 15 35 36 37 38 96 97 99
Other Noncurrent Operating Liabilities		 0.11 0.36 0.32 0.27 0.18 0.14 0.10 0.01
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 44 123 110 93 134 177 150 87
Total Preferred & Common Equity		 44 123 110 93 134 177 150 87
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 44 123 110 93 134 177 150 87
Common Stock		 128 231 233 234 315 382 385 396
Retained Earnings		 -85 -108 -123 -141 -182 -205 -235 -309

Annual Metrics And Ratios for Celcuity

This table displays calculated financial ratios and metrics derived from Celcuity's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 0.00% -79.65% -31.77% 3.12% -22.83% -202.98% -39.59% -69.77% -69.80%
EBIT Growth		 0.00% -78.85% -33.20% 1.57% -22.43% -196.73% -38.92% -68.14% -71.02%
NOPAT Growth		 0.00% -78.85% -33.25% 1.60% -22.43% -196.73% -38.92% -68.14% -71.02%
Net Income Growth		 0.00% -88.85% -19.66% 1.62% -28.74% -212.48% -36.36% -57.99% -75.26%
EPS Growth		 0.00% -61.54% 11.90% 2.70% -27.78% 0.00% 0.00% -1.89% -5.20%
Operating Cash Flow Growth		 0.00% -71.31% -22.80% 1.28% -19.12% -184.25% -77.28% -49.44% -55.11%
Free Cash Flow Firm Growth		 0.00% 0.00% -38.26% 8.73% -11.61% -203.72% -52.36% -47.85% -44.54%
Invested Capital Growth		 0.00% 79.45% 879.31% 19.20% -87.08% -1,404.10% 117.63% -2,361.88% -475.90%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% -1.08% 1.01% 16.64% -28.63% -15.88% -14.14% -16.95%
EBIT Q/Q Growth		 0.00% 0.00% -1.59% 0.68% 16.05% -28.24% -15.61% -13.91% -17.29%
NOPAT Q/Q Growth		 0.00% 0.00% -1.63% 0.68% 16.05% -28.27% -15.61% -13.91% -17.29%
Net Income Q/Q Growth		 0.00% 0.00% -1.37% 0.22% 15.46% -29.12% -13.58% -12.86% -18.95%
EPS Q/Q Growth		 0.00% 0.00% -5.71% 1.37% -8.24% 0.00% 0.00% 0.00% -8.43%
Operating Cash Flow Q/Q Growth		 0.00% -8.94% -7.22% -3.17% -5.98% -24.65% -10.28% -20.24% -12.44%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -0.63% 20.05% -35.03% -8.79% -20.82% -12.06%
Invested Capital Q/Q Growth		 0.00% 0.00% 80.92% 101.23% 10.78% 35.31% -84.17% 16.73% -24.86%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 99.46% 105.02% 94.34% 94.29% 99.14% 104.41% 102.49% 96.30% 98.69%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -58.99% -33.79% -26.37% -32.97% -61.12% -73.63% -39.88% -46.63% -87.54%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -1,289.33% -1,073.77% -1,951.87% 0.00% -17,175.55% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -58.99% -33.79% -26.37% -32.97% -61.12% -73.63% -39.88% -46.63% -87.54%
Return on Equity Simple (ROE_SIMPLE)		 -58.99% -19.92% -29.51% -38.14% -80.96% -43.09% -30.18% -45.63% -96.68%
Net Operating Profit after Tax (NOPAT)		 -2.33 -4.17 -5.55 -5.46 -6.69 -20 -28 -46 -79
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -16.60% -11.16% -6.85% -8.69% -18.34% -24.00% -12.59% -12.57% -23.13%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -26.22% -37.16%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -3.33 -5.95 -7.93 -7.81 -9.56 -28 -39 -66 -113
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.26 -5.85 -7.71 -7.47 -9.17 -28 -39 -66 -112
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 6.09 9.61 5.65 8.06 2.86 1.62 2.52 4.20
Price to Tangible Book Value (P/TBV)		 0.00 6.09 9.61 5.65 8.06 2.86 1.62 2.52 4.20
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 463.66 160.60 1,138.08 0.00 496.84 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.21 0.26 0.27 0.85
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.21 0.26 0.27 0.85
Financial Leverage		 -1.05 -1.01 -0.99 -0.98 -0.98 -1.01 -1.00 -1.01 -1.10
Leverage Ratio		 1.08 1.03 1.02 1.04 1.07 1.23 1.29 1.34 1.71
Compound Leverage Factor		 1.07 1.08 0.96 0.98 1.06 1.28 1.32 1.29 1.69
Debt to Total Capital		 0.00% 0.00% 0.08% 0.00% 0.07% 17.55% 20.73% 20.95% 45.81%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.08% 0.00% 0.07% 17.55% 20.73% 20.95% 45.81%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 99.92% 100.00% 99.93% 82.45% 79.27% 79.05% 54.19%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.53 -0.90 -0.56 -0.87
Net Debt to EBITDA		 0.00 0.00 3.23 0.00 1.27 2.51 3.44 2.18 1.23
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.53 -0.90 -0.56 -0.87
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.74 -1.27 -0.80 -1.23
Net Debt to NOPAT		 0.00 0.00 4.48 0.00 1.74 3.51 4.85 3.10 1.73
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.74 -1.27 -0.80 -1.23
Altman Z-Score		 0.00 198.50 213.96 65.22 40.85 6.02 2.74 2.90 0.22
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 13.27 42.36 38.07 21.12 10.26 34.06 25.46 13.43 7.71
Quick Ratio		 13.15 41.86 37.59 20.77 9.98 33.64 24.50 12.73 7.41
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -4.40 -6.09 -5.55 -6.20 -19 -29 -42 -61
Operating Cash Flow to CapEx		 -7,061.31% -2,062.97% -971.26% -1,577.77% -7,995.53% -24,953.86% -22,679.74% -55,110.66% -33,403.00%
Free Cash Flow to Firm to Interest Expense		 0.00 -9.74 -54,822.64 -34,932.75 -51,661.70 -14.92 -13.62 -7.96 -5.96
Operating Cash Flow to Interest Expense		 0.00 -10.96 -54,741.16 -37,727.74 -59,547.41 -16.09 -17.10 -10.10 -8.12
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -11.49 -60,377.27 -40,118.94 -60,292.17 -16.16 -17.17 -10.12 -8.14
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 -0.29 -0.06 0.47 0.56 0.07 -0.95 0.17 -3.78 -22
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 0.23 0.53 0.09 -0.49 -1.02 1.11 -3.95 -18
Enterprise Value (EV)		 0.00 160 219 90 83 127 83 209 349
Market Capitalization		 0.00 191 244 109 94 197 217 353 486
Book Value per Share		 $0.89 $3.11 $2.50 $1.88 $1.14 $4.61 $8.65 $5.77 $3.11
Tangible Book Value per Share		 $0.89 $3.11 $2.50 $1.88 $1.14 $4.61 $8.65 $5.77 $3.11
Total Capital		 5.61 31 25 19 12 83 169 177 213
Total Debt		 0.00 0.00 0.02 0.00 0.01 15 35 37 98
Total Long-Term Debt		 0.00 0.00 0.02 0.00 0.01 15 35 37 98
Net Debt		 -5.91 -31 -25 -19 -12 -70 -134 -144 -137
Capital Expenditures (CapEx)		 0.04 0.24 0.63 0.38 0.09 0.08 0.16 0.10 0.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.44 -0.34 -0.34 -0.40 -0.66 -1.44 -0.28 -4.18 -22
Debt-free Net Working Capital (DFNWC)		 5.47 24 25 18 11 83 168 176 213
Net Working Capital (NWC)		 5.47 24 25 18 11 83 168 176 213
Net Nonoperating Expense (NNE)		 0.98 2.08 1.93 1.90 2.78 9.76 13 17 32
Net Nonoperating Obligations (NNO)		 -5.91 -31 -25 -19 -12 -70 -134 -144 -137
Total Depreciation and Amortization (D&A)		 0.07 0.10 0.22 0.34 0.39 0.57 0.61 0.38 1.46
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) ($2.64) ($2.69) ($2.83)
Adjusted Weighted Average Basic Shares Outstanding		 6.31M 10.11M 10.21M 10.25M 10.30M 14.92M 15.42M 23.68M 39.45M
Adjusted Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) $0.00 ($2.69) ($2.83)
Adjusted Weighted Average Diluted Shares Outstanding		 6.31M 10.11M 10.21M 10.25M 10.30M 14.92M 21.69M 23.68M 39.45M
Adjusted Basic & Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 21.69M 30.45M 37.84M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.33 -4.17 -5.55 -5.46 -6.69 -20 -28 -46 -79
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 0.00 -13.18 -71,437.28 -49,089.94 -79,634.70 -22.46 -18.70 -12.43 -11.02
NOPAT to Interest Expense		 0.00 -9.23 -50,025.01 -34,362.96 -55,744.29 -15.72 -13.09 -8.70 -7.71
EBIT Less CapEx to Interest Expense		 0.00 -13.71 -77,073.39 -51,481.14 -80,379.46 -22.53 -18.78 -12.45 -11.04
NOPAT Less CapEx to Interest Expense		 0.00 -9.76 -55,661.12 -36,754.16 -56,489.05 -15.79 -13.17 -8.72 -7.74
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -13.69% -0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Celcuity

This table displays calculated financial ratios and metrics derived from Celcuity's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -92.59% -86.24% -69.19% -58.07% -79.32% -71.08% -79.96% -60.54% -55.72% -82.53% -58.70%
EBIT Growth		 -90.07% -84.14% -67.13% -56.82% -77.55% -69.51% -79.27% -61.29% -57.64% -84.65% -60.64%
NOPAT Growth		 -90.07% -84.14% -67.13% -56.82% -77.55% -69.51% -79.27% -61.29% -59.06% -84.65% -60.64%
Net Income Growth		 -80.74% -71.49% -50.46% -46.46% -68.95% -62.75% -81.03% -62.62% -61.87% -94.46% -71.19%
EPS Growth		 0.00% 0.00% 0.00% 1.49% -10.67% 0.00% -16.36% 6.06% 15.66% -33.85% -34.38%
Operating Cash Flow Growth		 -129.87% -54.79% -116.88% 14.41% -36.96% -95.54% -32.64% -86.99% -61.31% -49.82% -110.06%
Free Cash Flow Firm Growth		 -317.22% -172.06% -259.29% -8.86% 23.41% -6.52% 31.67% 24.01% -6.76% 23.76% -36.75%
Invested Capital Growth		 172.03% 117.63% 163.50% -109.75% -530.07% -2,361.88% -618.49% -8,002.71% -284.08% -475.90% -222.28%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -10.80% -9.47% -8.43% -20.19% -25.70% -4.44% -14.06% -7.21% -21.92% -22.42% 0.84%
EBIT Q/Q Growth		 -10.86% -9.35% -7.80% -19.99% -25.52% -4.40% -14.01% -7.95% -22.69% -22.28% 0.82%
NOPAT Q/Q Growth		 -10.86% -9.35% -7.80% -19.99% -25.52% -4.40% -14.01% -7.95% -23.79% -21.19% 0.82%
Net Income Q/Q Growth		 -9.37% -6.31% -3.08% -22.19% -26.16% -2.41% -14.66% -9.76% -25.59% -23.03% -0.94%
EPS Q/Q Growth		 -11.94% 0.00% 0.00% -20.00% -25.76% 21.69% 1.54% 3.13% -12.90% -24.29% 1.15%
Operating Cash Flow Q/Q Growth		 17.56% -1.85% -35.75% 24.91% -31.92% -45.42% 7.92% -5.85% -13.81% -35.06% -29.11%
Free Cash Flow Firm Q/Q Growth		 -18.96% 7.10% -28.93% 23.60% 16.30% -29.19% 17.29% 15.02% -17.59% 7.74% -48.33%
Invested Capital Q/Q Growth		 -18.18% -84.17% 634.35% -110.25% -3,507.56% 16.73% -68.33% -60.24% -71.01% -24.86% 5.80%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 102.35% 99.50% 95.15% 96.89% 97.39% 95.54% 96.08% 97.69% 100.00% 100.61% 102.39%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -60.24% -39.88% -48.03% -60.01% -82.85% -46.63% -57.17% -57.59% -77.47% -87.54% -115.39%
Cash Return on Invested Capital (CROIC)		 -2,499.64% -17,175.55% -2,793.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -60.24% -39.88% -48.03% -60.01% -82.85% -46.63% -57.17% -57.59% -77.47% -87.54% -115.39%
Return on Equity Simple (ROE_SIMPLE)		 -81.66% 0.00% -36.01% -44.49% -60.83% 0.00% -54.92% -46.74% -62.77% 0.00% -146.73%
Net Operating Profit after Tax (NOPAT)		 -7.45 -8.15 -8.78 -11 -13 -14 -16 -17 -21 -26 -25
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -5.82% -3.38% -3.40% -4.99% -7.40% -3.64% -4.48% -4.53% -6.61% -7.94% -9.47%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -7.81% - - - -11.95% -13.66%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -11 -12 -13 -15 -19 -20 -22 -24 -30 -36 -36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -10 -11 -12 -15 -19 -20 -22 -24 -29 -36 -36
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.45 1.62 1.80 2.19 2.17 2.52 4.92 2.90 3.69 4.20 4.41
Price to Tangible Book Value (P/TBV)		 3.45 1.62 1.80 2.19 2.17 2.52 4.92 2.90 3.69 4.20 4.41
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 101.94 496.84 81.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.34 0.26 0.29 0.33 0.39 0.27 0.28 0.54 0.65 0.85 1.14
Long-Term Debt to Equity		 0.34 0.26 0.29 0.33 0.39 0.27 0.28 0.54 0.65 0.85 1.14
Financial Leverage		 -1.00 -1.00 -1.00 -0.99 -1.03 -1.01 -1.02 -1.04 -1.09 -1.10 -1.12
Leverage Ratio		 1.33 1.29 1.32 1.38 1.52 1.34 1.37 1.56 1.71 1.71 1.84
Compound Leverage Factor		 1.36 1.29 1.26 1.34 1.48 1.28 1.32 1.52 1.71 1.72 1.89
Debt to Total Capital		 25.65% 20.73% 22.35% 24.63% 28.21% 20.95% 21.93% 35.25% 39.30% 45.81% 53.20%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 25.65% 20.73% 22.35% 24.63% 28.21% 20.95% 21.93% 35.25% 39.30% 45.81% 53.20%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 74.35% 79.27% 77.64% 75.37% 71.79% 79.05% 78.07% 64.75% 60.70% 54.19% 46.80%
Debt to EBITDA		 -0.45 -0.90 -0.81 -0.73 -0.63 -0.56 -0.50 -1.13 -1.01 -0.87 -0.79
Net Debt to EBITDA		 1.27 3.44 2.78 2.23 1.69 2.18 1.85 2.20 1.75 1.23 0.86
Long-Term Debt to EBITDA		 -0.45 -0.90 -0.81 -0.73 -0.63 -0.56 -0.50 -1.13 -1.01 -0.87 -0.79
Debt to NOPAT		 -0.63 -1.27 -1.14 -1.03 -0.90 -0.80 -0.70 -1.61 -1.43 -1.23 -1.11
Net Debt to NOPAT		 1.78 4.85 3.92 3.16 2.39 3.10 2.63 3.13 2.47 1.73 1.21
Long-Term Debt to NOPAT		 -0.63 -1.27 -1.14 -1.03 -0.90 -0.80 -0.70 -1.61 -1.43 -1.23 -1.11
Altman Z-Score		 2.85 3.26 3.18 3.03 1.71 3.71 6.59 2.51 2.20 1.25 0.23
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 9.74 25.46 28.26 21.58 11.15 13.43 11.23 14.95 10.36 7.71 6.61
Quick Ratio		 8.65 24.50 27.12 20.65 10.54 12.73 10.64 14.50 10.04 7.41 6.25
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -9.97 -9.26 -12 -9.12 -7.64 -9.87 -8.16 -6.93 -8.15 -7.52 -11
Operating Cash Flow to CapEx		 -76,896.46% -8,460.30% -184,168.28% -199,053.40% -24,002.79% -56,686.51% -19,033.14% -28,109.63% -40,491.73% -61,507.42% -59,755.00%
Free Cash Flow to Firm to Interest Expense		 -18.54 -13.66 -9.61 -6.94 -5.57 -7.06 -5.83 -3.07 -2.44 -2.30 -3.51
Operating Cash Flow to Interest Expense		 -17.31 -13.98 -10.36 -7.35 -9.29 -13.27 -12.19 -7.99 -6.15 -8.48 -11.26
Operating Cash Flow Less CapEx to Interest Expense		 -17.33 -14.15 -10.37 -7.35 -9.33 -13.29 -12.25 -8.02 -6.16 -8.49 -11.28
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1.05 0.17 1.23 -0.13 -4.54 -3.78 -6.36 -10 -17 -22 -20
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 2.52 1.11 3.16 -1.42 -5.59 -3.95 -7.59 -10 -13 -18 -14
Enterprise Value (EV)		 108 83 100 131 104 209 518 325 385 349 275
Market Capitalization		 150 217 222 241 202 353 658 512 552 486 383
Book Value per Share		 $2.91 $8.65 $5.68 $5.02 $4.21 $5.77 $4.39 $5.66 $4.04 $3.11 $2.33
Tangible Book Value per Share		 $2.91 $8.65 $5.68 $5.02 $4.21 $5.77 $4.39 $5.66 $4.04 $3.11 $2.33
Total Capital		 59 169 159 146 129 177 171 273 247 213 185
Total Debt		 15 35 35 36 37 37 38 96 97 98 99
Total Long-Term Debt		 15 35 35 36 37 37 38 96 97 98 99
Net Debt		 -42 -134 -122 -110 -97 -144 -140 -187 -167 -137 -107
Capital Expenditures (CapEx)		 0.01 0.11 0.01 0.00 0.05 0.03 0.09 0.06 0.05 0.05 0.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.57 -0.28 0.82 -0.52 -4.94 -4.18 -6.84 -11 -18 -22 -21
Debt-free Net Working Capital (DFNWC)		 58 168 158 146 129 176 171 272 246 213 185
Net Working Capital (NWC)		 58 168 158 146 129 176 171 272 246 213 185
Net Nonoperating Expense (NNE)		 3.44 3.43 3.16 4.05 5.18 5.04 5.87 6.72 8.75 11 12
Net Nonoperating Obligations (NNO)		 -42 -134 -122 -110 -97 -144 -140 -187 -167 -137 -107
Total Depreciation and Amortization (D&A)		 0.16 0.16 0.10 0.10 0.10 0.09 0.09 0.27 0.51 0.59 0.59
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.75) ($0.69) ($0.55) ($0.66) ($0.83) ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86)
Adjusted Weighted Average Basic Shares Outstanding		 14.94M 15.42M 21.68M 21.96M 22.12M 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.66) ($0.83) ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86)
Adjusted Weighted Average Diluted Shares Outstanding		 15.46M 15.42M 21.96M 21.96M 22.12M 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 15.46M 21.69M 21.96M 22.09M 24.20M 30.45M 31.23M 37.03M 37.13M 37.84M 37.87M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.45 -8.15 -8.78 -11 -13 -14 -16 -17 -21 -26 -25
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -19.80 -17.17 -10.10 -11.45 -13.77 -14.12 -16.06 -10.74 -8.91 -11.12 -11.35
NOPAT to Interest Expense		 -13.86 -12.02 -7.07 -8.01 -9.64 -9.88 -11.24 -7.52 -6.29 -7.79 -7.95
EBIT Less CapEx to Interest Expense		 -19.82 -17.33 -10.11 -11.45 -13.81 -14.14 -16.12 -10.77 -8.92 -11.14 -11.37
NOPAT Less CapEx to Interest Expense		 -13.88 -12.18 -7.08 -8.02 -9.68 -9.91 -11.31 -7.55 -6.31 -7.80 -7.97
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Key Financial Trends

Celcuity Inc. (NASDAQ: CELC) continues to operate without generating revenue, reflecting its status as an early-stage biotech company primarily focused on research and development. From Q3 2022 through Q1 2025, total revenue remained at zero across all quarters, indicating the company has yet to achieve commercial sales.

Financial Performance and Trends:

  • Consistent net losses: Celcuity reported net losses each quarter, with Q1 2025 net loss at approximately $37.0 million, up slightly from $36.7 million in Q4 2024 and significantly higher compared to $11.6 million in Q4 2022, showing increasing losses over time.
  • High and increasing operating expenses: Operating expenses rose from about $11.6 million in Q4 2022 to around $36.1 million in Q1 2025, driven largely by Research & Development (R&D) expenses, which grew from $10.6 million to $32.2 million over the same period.
  • Negative cash flow from operations across all quarters, reaching -$35.9 million in Q1 2025, highlighting ongoing cash burn primarily related to R&D and SG&A expenses without offsetting revenue inflows.

Balance Sheet and Liquidity:

  • Strong liquidity position: As of Q1 2025, Celcuity held approximately $16.5 million in cash and equivalents, supplemented by $189.2 million in short-term investments, collectively providing solid financial resources totaling over $205 million.
  • Stable equity base: Total common equity stood at approximately $86.7 million in Q1 2025, down from $149.7 million in Q4 2024 and $43.5 million in Q3 2022, reflecting accumulated losses but still maintaining a positive net equity position.

Capital Activities:

  • Continued investment activity: The company frequently buys and sells investments to manage liquidity; Q1 2025 investing activities netted positive cash inflows of about $24.3 million, indicating active portfolio management.
  • Financing activities have been mixed but modest recently; for example, Q1 2025 financing activities provided about $5.6 million, a decline compared to earlier, larger financing rounds.

Additional Considerations:

  • Declining cash position: Despite sizeable investment holdings, Celcuity’s cash and equivalents declined by about $6.0 million in Q1 2025, consistent with significant negative operating cash flow.
  • No reported income tax expenses for all periods, consistent with operating losses and lack of profitability.
  • Interest expense and interest income roughly offset each other, with interest expense slightly above interest income in Q1 2025, contributing additional expense pressure but at manageable levels relative to operating losses.

Summary:

Celcuity remains a pre-revenue biotech company heavily investing in research and development, as reflected by rising R&D expenses and sustained net losses over the last four years. The firm maintains a strong liquidity position supported by cash and short-term investments totaling over $200 million as of early 2025, which should provide a runway for continued operations and clinical development. However, operating cash burn increased to nearly $36 million in Q1 2025, exceeding prior periods. The absence of revenues and persistent losses represent ongoing risk for investors, balanced by the company's substantial financial resources. Retail investors should monitor Celcuity’s progress in clinical milestones and potential pathways to commercialization that could eventually translate into revenue generation and improved financial performance.

09/16/25 01:55 PM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Celcuity's Financials

When does Celcuity's fiscal year end?

According to the most recent income statement we have on file, Celcuity's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Celcuity's net income changed over the last 8 years?

Celcuity's net income appears to be on an upward trend, with a most recent value of -$111.78 million in 2024, rising from -$3.31 million in 2016. The previous period was -$63.78 million in 2023. See where experts think Celcuity is headed by visiting Celcuity's forecast page.

What is Celcuity's operating income?
Celcuity's total operating income in 2024 was -$113.27 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $113.27 million
How has Celcuity's revenue changed over the last 8 years?

Over the last 8 years, Celcuity's total revenue changed from $0.00 in 2016 to $0.00 in 2024, a change of 0.0%.

How much debt does Celcuity have?

Celcuity's total liabilities were at $129.50 million at the end of 2024, a 151.7% increase from 2023, and a 28,978.6% increase since 2016.

How much cash does Celcuity have?

In the past 8 years, Celcuity's cash and equivalents has ranged from $2.64 million in 2017 to $84.29 million in 2021, and is currently $22.52 million as of their latest financial filing in 2024.

How has Celcuity's book value per share changed over the last 8 years?

Over the last 8 years, Celcuity's book value per share changed from 0.89 in 2016 to 3.11 in 2024, a change of 250.3%.


Related Companies

This page (NASDAQ:CELC) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners
New Biotech Backed by Proven Incubator Now Open to Public
A successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...
i2i Marketing Group, LLC | Sponsoredtc pixel
Sean Hannity: Help Protect Your Retirement
This Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...
Goldco Precious Metals | Sponsoredtc pixel
What a Former CIA Agent Knows About the Coming Collapse
This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...
Advantage Gold | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
Trump’s Plan May Undo 1933’s Biggest Financial Injustice
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...
American Hartford Gold | Sponsoredtc pixel
Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...
Brownstone Research | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel